Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-013360

Chief Legal Officer sold 291 shares at $8.76 ($2,549)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SUMER JACQUELYN L Chief Legal Officer 2023-05-18 Sale −291 $8.76 $2,549 46,114 D
Open-market sales · 291 sh · avg $8.76 · $2,549
Loading xslF345X04/doc4.xml…